Antibiotic therapy in the treatment of bacterial infections of the small animal central nervous system

Authors

  • Rafaela Scheer Bing Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul (FAVET/FRGS)
  • Paula Cristina Sieczkowski Gonzalez Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul (FAVET/FRGS)
  • Márcio Poletto Ferreira Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul (FAVET/FRGS)

Keywords:

Antibiotic therapy, CNS bacterial infection, blood-brain-barrier, veterinary neurology

Abstract

Although infections in the central nervous system are less common than infections in other organics systems, they can cause life-threatening consequences and are a challenge for small animal practitioners. Among the factors that make these infections difficult to treat are the fact that it is surrounded by the blood-brain barrier, that hinders penetration of many substances, and the difficulty of obtaining positive results when trying to isolate the causative agent through spinal tap. This article aims to describe the blood-brain barrier, the most common antimicrobials used to treat bacterial infections in the central nervous system and their main applications in small animal practice. In the veterinary literature, trimethoprim, sulfonamides, chloramphenicol, and metronidazole are cited as antimicrobials with excellent penetration on the blood-brain barrier; oxacillin, penicillin’s, ceftriaxone, moxalactam, tetracyclines and carbenicillin with intermediate penetration; and aminoglycosides, first-generation cephalosporins, and clindamycin with little penetration. It was concluded that knowing the blood-brain barrier characteristics, pharmacokinetics and pharmacodynamics of antimicrobial agents, along with the main etiological agents, are the key to choose the most appropriate antibiotic to be applied in each individual case. It is noticed that in the veterinary literature there are few reports describing aspects of pharmacokinetics and pharmacodynamics in feline and canine species, requiring more studies in this area.

References

CHRISMAN, C.; MARIANI, C.; PLATT, S.; CLEMMONS, R. Dor cervical. In: Neurologia para o clínico de pequenos animais. 1ª ed., São Paulo: Roca, p.161-184, 2005.

CIZINAUSKAS, S.; TIPOLD,A.; FATZER, R.; BURNENS, A.; JAGGY, A.Streptococcal meningoencephalomyelitis in 3 dogs. Journal of Veterinary Internal Medicine, v.15, p.157-161, 2001. Available from: <http://onlinelibrary.wiley.com/doi/10.1111/j.1939-1676.2001.tb01250.x/pdf> Accessed Jan 17, 2018. doi: 10.1111/j.1939-1676.2001.tb01250.x.

DAVSON, H. The blood-brain barrier. The Journal of Physiology, v.255, p.1-28, 1976. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1309232/ pdf/jphysio l00857-0017.pdf> Accessed Jan 17, 2018. doi: 10.1113/jphysiol.1976.sp011267.

DE LAHUNTA, A.; GLASS, E.; KENT, M. Cerebrospinal fluid and hydrocephalus. In: Veterinary neuroanatomy and clinical neurology. 4a ed., Maryland Heights: Elsevier, Cap.4, p.78-101, 2015.

DEWEY, C.W. Encephalopathies: Disorders of the brain. In: DEWEY, C. W.; DA COSTA, R. C. Practical guide to canine and feline neurology. 3a ed., England: Blackwell publishing, Cap.7, p.141-236, 2016.

DEWEY, C.W.; DA COSTA, R.C. Disorders of the cauda equina In: Practical guide to canine and feline neurology. 3ª ed., England: Blackwell publishing, Cap.14, p.405-421, 2016.

FENNER, W.R. Moléstias do encéfalo. In: ETTINGER, S J.; FELDMAN, E.C. Tratado de Medicina Interna. 4ª ed., São Paulo: Manole, v.1, Cap.82, p.819-889, 1997.

FLÓRIO, J.C.; SOUSA, A.B. Farmacocinética. In: SPINOSA, H.S.; GÓRNIAK, S.L.; BERNARDI, M.,M. Farmacologia aplicada à Medicina Veterinária. 5ª ed., Rio de Janeiro: Guanabara Koogan, Cap.4, p.27-45, 2011.

GLAUS, T.; REUSCH, C.; AESCHBACHER, G. Neuropharmacology. In: PLATT, S. Small animal neurology an illustrated text. 1a ed., Hannover: Schlütersche, Cap.9, p.183-197, 2010.

GÓRNIAK, S.L. Sulfas, quinolonas e outros quimioterápicos. In: SPINOSA, H.S.; GÓRNIAK, S.L.; BERNARDI, M.M. Farmacologia aplicada à Medicina Veterinária. 5a ed., Rio de Janeiro: Guanabara Koogan, Cap.36, p.432-441, 2011.

KENT, M. Bacterial Infections of the Central Nervous System. In: GREENE, C.E. Infectious diseases of the dog and the cat. 4a ed., St. Louis: Elsevier, Cap.91, p.1045-1058, 2012.

LECOUTEUR, R.A.; CHILD, G. Afecções da medula espinhal. In: ETTINGER, S.J.; FELDMAN, E.C. Tratado de medicina interna. 4ª ed., São Paulo: Manole, v.1, p.890-1025, 1997.

LEE, G.; DALLAS, S.; HONG, M.; BENDAYAN, R. Drug Transporters in the Central Nervous system: brain barriers and brain parenchyma considerations. Pharmacological Reviews, Baltimore, v.53, n.4, p.569–596, 2001. Available from: < http://pharmrev. aspetjournals.org/content/pharmrev/53/4/569.full.pdf > Accessed Jan 17, 2018.

LIN, K.; SÁ, P.N.D. Aspectos farmacocinéticos e farmacodinâmicos dos agentes antibacterianos no sistema nervoso central. Arquivos Catarinenses de Medicina, Florianópolis, v.31, n.1/2, p.25-30, 2002. Available from: <http://www.acm.org.br/ revista/pdf/artigos/30.pdf> Accessed Jan 17, 2018.

MANKIN, J.M. Top 5 Antibiotics for Neurologic Infections in Dogs. Clinicians brief, Ontário, v.23, n.1, p.83-86, 2017. Available from: <https://www.cliniciansbrief.com/sites/ default/files/attachments/Top%205%20Antibiotics%20for%20Neurologic%20Infections%20in%20Dogs.pdf> Accessed Jan 17, 2018.

MOYES, C.D.; SCHULTE, P.M. Organização funcional do sistema nervoso central. In: Princípios de fisiologia animal. 2ª ed., Porto Alegre: Artmed, Cap7, p.306-347, 2010.

NAU, R.; SORGEL, F.; PRANGE, H.W. Pharmacokinetic optimization of treatment of bacterial central nervous system infections. Clinical pharmacokinetics, Auckland, v.35, p.223-246, 1998. Available from: <https://www.ncbi.nlm.nih.gov/pubmed/9784935> Accessed Jan 17, 2018. doi: 10.2165/00003088-199835030-00005.

NEVES, I.V.; TUDURY, E.A.; DA COSTA, R.C. Fármacos utilizados no tratamento das afecções neurológicas de cães e gatos. Semina: Ciências agrárias, Londrina, v.31., n.3, p.745-766, 2010. Available from: < http://www.redalyc.org/html/4457/445744097026/ >. Accessed Jan 17, 2018

RADAELLI, S.T.; PLATT, S.R. Bacterial Meningoencephalomyelitis in Dogs: A Retrospective Study of 23 Cases (1990-1999). Journal of Veterinary Internal Medicine, v.16. p.159-163, 2002. Available from: <http://onlinelibrary.wiley.com/doi/10.1111/j.1939-1676.2002.tb02348.x/epdf>. Accessed Jan 17, 2018. doi: 10.1111/j.1939-1676.2002.tb02348.x

SANDERS, S.G. Disorders of Hearing and Balance: the Vestibulocochlear Nerve (CN VIII) and Associated Structures. In: DEWEY, C.W.; DA COSTA, R.C. Practical guide to canine and feline neurology. 3a ed., England: Blackwell publishing, Cap.11, p.277-297, 2016.

SCHATZBER, S.; NGHIEM, P. Infectious and inflammatory diseases of the CNS. In: PLATT, S.; GAROSI, L. Small animal neurological emergencies. 1a ed., London: Manson, Cap.19, p.341-362, 2012.

SPINOSA, H.S. Antibióticos que Interferem na Síntese da Parede Celular: Betalactâmicos. In: SPINOSA, H.S.; GÓRNIAK, S.L.; BERNARDI, M.M. Farmacologia aplicada à Medicina Veterinária. 5ª ed., Rio de Janeiro: Guanabara Koogan, Cap. 37, p.442-449, 2011.

SPINOSA, H.S. Antibióticos Bacteriostáticos que Interferem na Síntese Proteica: Macrolídios, Lincosamidas, Pleuromutilinas, Estreptograminas, Tetraciclinas, Cloranfenicol e Derivados. In: SPINOSA, H.S.; GÓRNIAK, S.L.; BERNARDI, M.M. Farmacologia aplicada à Medicina Veterinária. 5ª ed., Rio de Janeiro: Guanabara Koogan, Cap. 40, p.464-473, 2011.

STIRLING, D.P.; KOOCHESFAHANI, J.D.S.; TETZLAFF, W. Minocycline as a neuroprotective agent. The neuroscientist, Baltimore, v.11, n.4, p.308-322, 2005.

VIANA, F.A.B. Guia Terapêutico Veterinário. 3ª ed., Lagoa Santa: Gráfica e Editora CEM, 2007. 553p.

Published

2022-11-10

How to Cite

BING, R. S.; GONZALEZ, P. C. S.; FERREIRA, M. P. Antibiotic therapy in the treatment of bacterial infections of the small animal central nervous system. Ciência Animal, [S. l.], v. 31, n. 2, p. 120–129, 2022. Disponível em: https://revistas.uece.br/index.php/cienciaanimal/article/view/9363. Acesso em: 4 dec. 2024.